Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline Baratz goes in depth to discover more about the people behind innovative companies ushering in the latest trends in healthcare.
CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as a picture is worth a thousand words, a single descriptor can have the information content of a thousand descriptors embedded in it. The CureMatch presentation, titled ‘Kolmogorov Complexity, Logical Depth, etc. in Selection of Descriptors for Deep Learning in Medicine’ was given by Igor Tsigelny, Ph.D and Eden Romm, B.S.
Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that recognizes the top companies, technologies, and products in the global Artificial Intelligence (AI) market. The CureMatch precision medicine technology utilizes machine learning features and rules-based decision support to offer ranked combination cancer treatment options and has succeeded in pushing ingenuity to be identified as one of the best AI solutions in 2018.
Jessica Federer Joins Advisory Board to Advance Cancer Cures. Stephane Richard and Jessica Federer to speak at PMLS2018. SAN DIEGO, CA – June 26, 2018 – CureMatch, Inc., a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine, announces the addition of Jessica Federer to its advisory board. Ms. […]
SAN DIEGO, CA – June 22, 2018 – CureMatch, Inc. offers results of an artificial intelligence (AI) based cancer study at the WIN Symposium 2018 in Paris, June 25-26. CureMatch Co-founder Razelle Kurzrock, M.D. is the Organizing Committee Co-Chair of this 10th anniversary Worldwide Innovative Networking in Personalized Cancer Research event. CureMatch data scientist, Alexander […]